Kintor Pharmaceutical said that it has wrapped up patient enrollment for the phase 2 clinical trial of KX-826 (pyrilutamide) in China for the treatment of acne vulgaris. The Chinese biotech company has enrolled a total of 160 patients for the mid-stage clinical trial. According to Kintor Pharmaceutical, the randomized, double-blind, placebo-controlled clinical study to be […]
Kintor Pharmaceutical has secured an emergency use authorization (EUA) for proxalutamide (GT-0918) for the treatment of hospitalized patients with Covid-19 infections in Paraguay. The EUA issued by the Ministry of Public Health and Social Welfare (MSPBS) is for the use of the nonsteroidal antiandrogen in patients admitted in MSPBS hospitals. The Barrio Obrero hospital, which […]
